<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35359978</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2.</ArticleTitle><Pagination><StartPage>817835</StartPage><MedlinePgn>817835</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">817835</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.817835</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) and Coxsackievirus A16 (CV-A16) are the main causative agents of hand, foot and mouth disease (HFMD) worldwide. Studies showed that EV-A71 and CV-A16 antagonize the interferon (IFN) signaling pathway; however, how IFN controls this viral infection is largely unknown. Here, we identified an IFN-stimulated gene, <i>Transmembrane Protein 106A</i> (<i>TMEM106A)</i>, encoding a protein that blocks EV-A71 and CV-A16 infection. Combined approaches measuring viral infection, gene expression, and protein interactions uncovered that TMEM106A is required for optimal IFN-mediated viral inhibition and interferes with EV-A71 binding to host cells on the receptor scavenger receptor class B member 2 (SCARB2). Our findings reveal a new mechanism contributing to the IFN-mediated defense against EV-A71 and CV-A16 infection and provide a potential strategy for HFMD treatment by using the antiviral role of TMEM106A against enterovirus.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Guo, Zeng, Ji, Meng, Lei, Yang and Mu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xuemin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population, Meizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Shinuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, HKU-SZH &amp; Faculty of Medicine,The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Xiaoxin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin University and Health-Biotech United Group Joint Laboratory of Innovative Drug Development and Translational Medicine, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiaobin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population, Meizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Nanfeng</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population, Meizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population, Meizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin University and Health-Biotech United Group Joint Laboratory of Innovative Drug Development and Translational Medicine, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004267" MajorTopicYN="N">DNA Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SCARB2</Keyword><Keyword MajorTopicYN="N">TMEM106A</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">interferon-stimulated gene</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35359978</ArticleId><ArticleId IdType="pmc">PMC8963425</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.817835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goksugur N, Goksugur S. Hand, Foot, and Mouth Disease. N Engl J Med (2010) 362:e49. doi:&#xa0;10.1056/NEJMicm0910628</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMicm0910628</ArticleId><ArticleId IdType="pubmed">20375401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Yang Q-Z, Liang J, Dong S-Y, Liu Z-J, Wang L-X. Clinical Features and Management Outcomes of Severe Hand, Foot and Mouth Disease. Med Princ Pract (2012) 21:355&#x2013;9. doi:&#xa0;10.1159/000334619</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000334619</ArticleId><ArticleId IdType="pubmed">22188681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni XF, Li X, Xu C, Xiong Q, Xie BY, Wang LH, et al. . Risk Factors for Death From Hand&#x2013;Foot&#x2013;Mouth Disease: A Meta&#x2013;Analysis. Epidemiol Infect (2020) 148:e44. doi:&#xa0;10.1017/S0950268819002279</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268819002279</ArticleId><ArticleId IdType="pmc">PMC7058831</ArticleId><ArticleId IdType="pubmed">32102711</ArticleId></ArticleIdList></Reference><Reference><Citation>Thammasonthijarern N, Kosoltanapiwat N, Nuprasert W, Sittikul P, Sriburin P, Pan&#x2013;ngum W, et al. . Molecular Epidemiological Study of Hand, Foot, and Mouth Disease in a Kindergarten&#x2013;Based Setting in Bangkok, Thailand. Pathogens (2021) 10:576. doi:&#xa0;10.3390/pathogens10050576</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050576</ArticleId><ArticleId IdType="pmc">PMC8150733</ArticleId><ArticleId IdType="pubmed">34068676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. Cellular Receptors for Enterovirus A71. J BioMed Sci (2020) 27:23. doi:&#xa0;10.1186/s12929-020-0615-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. Hand, Foot and Mouth Disease (HFMD): Emerging Epidemiology and the Need for a Vaccine Strategy. Med Microbiol Immunol (2016) 205:397&#x2013;407. doi:&#xa0;10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E-J, Shin Y-J, Kim J-H, Kim T-G, Chang S-Y. Enterovirus 71 Infection and Vaccines. Clin Exp Vaccine Res (2017) 6:4. doi:&#xa0;10.7774/cevr.2017.6.1.4</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. Structure of Human Enterovirus 71 in Complex With a Capsid&#x2013;Binding Inhibitor. Proc Natl Acad Sci (2013) 110:5463&#x2013;7. doi:&#xa0;10.1073/pnas.1222379110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X-Y, Guo L, Huang D-Y, Chang X-L, Qiu Q-C. Distribution of EV71 Receptors SCARB2 and PSGL&#x2013;1 in Human Tissues. Virus Res (2014) 190:40&#x2013;52. doi:&#xa0;10.1016/j.virusres.2014.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.05.007</ArticleId><ArticleId IdType="pubmed">24997419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-W, Lin H-Y, Tsou Y-L, Chitra E, Hsiao K-N, Shao H-Y, et al. . Human SCARB2&#x2013;Mediated Entry and Endocytosis of EV71. PloS One (2012) 7:e30507. doi:&#xa0;10.1371/journal.pone.0030507</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H-Y, Yang Y-T, Yu S-L, Hsiao K-N, Liu C-C, Sia C, et al. . Caveolar Endocytosis Is Required for Human PSGL&#x2013;1&#x2013;Mediated Enterovirus 71 Infection. J Virol (2013) 87:9064&#x2013;76. doi:&#xa0;10.1128/JVI.00573-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SR, Sarnow P. Enterovirus 71 Contains a Type I IRES Element That Functions When Eukaryotic Initiation Factor eIF40047 Is Cleaved. Virology (2003) 315:259&#x2013;66. doi:&#xa0;10.1016/S0042-6822(03)00544-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00544-0</ArticleId><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An Update on Enterovirus 71 Infection and Interferon Type I Response. Rev Med Virol (2019) 29:e2016. doi:&#xa0;10.1002/rmv.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung H, He M-L. The Virology and Developments Toward Control of Human Enterovirus 71. Crit Rev Microbiol (2011) 37:313&#x2013;27. doi:&#xa0;10.3109/1040841X.2011.580723</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiecki M, Colonna M. Type I Interferons: Diversity of Sources, Production Pathways and Effects on Immune Responses. Curr Opin Virol (2011) 1:463&#x2013;75. doi:&#xa0;10.1016/j.coviro.2011.10.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2011.10.026</ArticleId><ArticleId IdType="pmc">PMC3572907</ArticleId><ArticleId IdType="pubmed">22440910</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-I, Lin J-Y, Chen S-H. EV71 Infection Induces IFN&#x3b2; Expression in Neural Cells. Viruses (2019) 11:1121. doi:&#xa0;10.3390/v11121121</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Su R, Wang W, Liang Y, Zeng X, Shereen MA, et al. . EV71 Infection Induces Neurodegeneration via Activating TLR7 Signaling and IL&#x2013;6 Production. PloS Pathog (2019) 15:e1008142. doi:&#xa0;10.1371/journal.ppat.1008142</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008142</ArticleId><ArticleId IdType="pmc">PMC6932824</ArticleId><ArticleId IdType="pubmed">31730654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-L, Lu M-Y, Chuang C-F, Kuo Y, Lin H-E, Li F-A, et al. . TLR7 Is Critical for Anti&#x2013;Viral Humoral Immunity to EV71 Infection in the Spinal Cord. Front Immunol (2021) 11:614743. doi:&#xa0;10.3389/fimmu.2020.614743</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.614743</ArticleId><ArticleId IdType="pmc">PMC7935532</ArticleId><ArticleId IdType="pubmed">33679702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, et al. . The 3C Protein of Enterovirus 71 Inhibits Retinoid Acid&#x2013;Inducible Gene I&#x2013;Mediated Interferon Regulatory Factor 3 Activation and Type I Interferon Responses. J Virol (2010) 84:8051&#x2013;61. doi:&#xa0;10.1128/JVI.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R-L, Kao L-T, Lin S-J, Wang RY-L, Shih S-R. MDA5 Plays a Crucial Role in Enterovirus 71 RNA&#x2013;Mediated IRF3 Activation. PloS One (2013) 8:e63431. doi:&#xa0;10.1371/journal.pone.0063431</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of Interferon Regulatory Factor 7 by Enterovirus 71 3c Suppresses Cellular Responses. J Virol (2013) 87:1690&#x2013;8. doi:&#xa0;10.1128/JVI.01855-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H-C, Wang H-C, Shih S-R, Teng I-F, Tseng C-P, Hsu JT-A. Synergistic Inhibition of Enterovirus 71 Replication by Interferon and Rupintrivir. J Infect Dis (2011) 203:1784&#x2013;90. doi:&#xa0;10.1093/infdis/jir174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang Z, Zhao X, Yu R, Zhang X, Wu S, et al. . Enterovirus 71 Inhibits Cellular Type I Interferon Signaling by Downregulating JAK1 Protein Expression. Viral Immunol (2014) 27:267&#x2013;76. doi:&#xa0;10.1089/vim.2013.0127</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0127</ArticleId><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M. Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors. Immunol Rev (1995) 148:5&#x2013;18. doi:&#xa0;10.1111/j.1600-065X.1995.tb00090.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1995.tb00090.x</ArticleId><ArticleId IdType="pubmed">8825279</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M-L, Lee Y-P, Wang Y-F, Lei H-Y, Liu C-C, Wang S-M, et al. . Type I Interferons Protect Mice Against Enterovirus 71 Infection. J Gen Virol (2005) 86:3263&#x2013;9. doi:&#xa0;10.1099/vir.0.81195-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Qu L, Hu J, Li G, Lv P, Ma D, et al. . Transmembrane Protein 106A Is Silenced by Promoter Region Hypermethylation and Suppresses Gastric Cancer Growth by Inducing Apoptosis. J Cell Mol Med (2014) 18:1655&#x2013;66. doi:&#xa0;10.1111/jcmm.12352</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12352</ArticleId><ArticleId IdType="pmc">PMC4190911</ArticleId><ArticleId IdType="pubmed">24975047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Xu J, Wang H, Zhang J, Zhong J, Zou X, et al. . TMEM106a is a Novel Tumor Suppressor in Human Renal Cancer. Kidney Blood Press Res (2017) 42:853&#x2013;64. doi:&#xa0;10.1159/000484495</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484495</ArticleId><ArticleId IdType="pubmed">29131025</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhu H. TMEM106A Inhibits Cell Proliferation, Migration, and Induces Apoptosis of Lung Cancer Cells. J Cell Biochem (2019) 120:7825&#x2013;33. doi:&#xa0;10.1002/jcb.28057</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.28057</ArticleId><ArticleId IdType="pubmed">30456879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai H, Xu D, Su J, Jang J, Chen Y. Transmembrane Protein 106a Activates Mouse Peritoneal Macrophages via the MAPK and NF&#x2013;&#x3ba;B Signaling Pathways. Sci Rep (2015) 5:12461. doi:&#xa0;10.1038/srep12461</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep12461</ArticleId><ArticleId IdType="pmc">PMC4516968</ArticleId><ArticleId IdType="pubmed">26215746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Feng T, Zhou X, Sullivan PM, Hu F, Lou Y, et al. . Inactivation of TMEM106A Promotes Lipopolysaccharide&#x2013;Induced Inflammation via the MAPK and NF&#x2013;&#x3ba;b Signaling Pathways in Macrophages. Clin Exp Immunol (2021) 203:125&#x2013;36. doi:&#xa0;10.1111/cei.13528</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13528</ArticleId><ArticleId IdType="pmc">PMC7744488</ArticleId><ArticleId IdType="pubmed">33006758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang W, Wang X, Zhang X, Tian H, Deng H, et al. . Identification of New Type I Interferon&#x2013;Stimulated Genes and Investigation of Their Involvement in IFN&#x2013;&#x3b2; Activation. Protein Cell (2018) 9:799&#x2013;807. doi:&#xa0;10.1007/s13238-018-0511-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-018-0511-1</ArticleId><ArticleId IdType="pmc">PMC6107486</ArticleId><ArticleId IdType="pubmed">29427062</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao D, Yan F, Zhang X, Gao G. TMEM106A Inhibits Enveloped Virus Release From Cell Surface. iScience (2022) 25(2):103843. doi:&#xa0;10.1016/j.isci.2022.103843</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.103843</ArticleId><ArticleId IdType="pmc">PMC8844723</ArticleId><ArticleId IdType="pubmed">35198896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng S, Meng X, Huang Q, Lei N, Zeng L, Jiang X, et al. . Spiramycin and Azithromycin, Safe for Administration to Children, Exert Antiviral Activity Against Enterovirus A71 In Vitro and In Vivo . Int J Antimicrob Agents (2019) 53:362&#x2013;9. doi:&#xa0;10.1016/j.ijantimicag.2018.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2018.12.009</ArticleId><ArticleId IdType="pubmed">30599241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang P, Wang N, Zhang J, Li J, Guo H, et al. . The Binding of a Monoclonal Antibody to the Apical Region of SCARB2 Blocks EV71 Infection. Protein Cell (2017) 8:590&#x2013;600. doi:&#xa0;10.1007/s13238-017-0405-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0405-7</ArticleId><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W-F, Huang R-T, Chien K-Y, Huang J-Y, Lau K-S, Jheng J-R, et al. . Host MicroRNA Mir&#x2013;197 Plays a Negative Regulatory Role in the Enterovirus 71 Infectious Cycle by Targeting the RAN Protein. J Virol (2016) 90:1424&#x2013;38. doi:&#xa0;10.1128/JVI.02143-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02143-15</ArticleId><ArticleId IdType="pmc">PMC4719623</ArticleId><ArticleId IdType="pubmed">26581983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsd&#xf6;rfer B, Giese T, et al. . Quantitative Expression of Toll&#x2013;Like Receptor 1&#x2013;10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides. J Immunol (2002) 168:4531&#x2013;7. doi:&#xa0;10.4049/jimmunol.168.9.4531</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.9.4531</ArticleId><ArticleId IdType="pubmed">11970999</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, Su W, An D, Xu L, et al. . Establishment of Cell Lines With Increased Susceptibility to EV71/CA16 by Stable Overexpression of SCARB2. Virol J (2013) 10:250. doi:&#xa0;10.1186/1743-422X-10-250</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, et al. . Unexpected Mode of Engagement Between Enterovirus 71 and Its Receptor SCARB2. Nat Microbiol (2019) 4:414&#x2013;9. doi:&#xa0;10.1038/s41564-018-0319-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnhammer EL, von Heijne G, Krogh A. A Hidden Markov Model for Predicting Transmembrane Helices in Protein Sequences. Proc Int Conf Intell Syst Mol Biol (1998) 6:175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">9783223</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, Schwake M, Schr&#xf6;der J, Hughes H, Blanz J, Jin X, et al. . LIMP&#x2013;2 Is a Receptor for Lysosomal Mannose&#x2013;6&#x2013;Phosphate&#x2013;Independent Targeting of Beta&#x2013;Glucocerebrosidase. Cell (2007) 131:770&#x2013;83. doi:&#xa0;10.1016/j.cell.2007.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.018</ArticleId><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>